Award

Therapeutic Modulation of Cardiomyocyte SASP Factor IGFBP5 in Metabolic Heart Failure

Description: Cardiac adaptation to endurance exercise requires precise metabolic and mitochondrial flexibility to enable physiological growth. Perturbation of the underlying molecular pathways contributes to exercise intolerance and heart failure (HF), particularly in settings of metabolic or mitochondrial stress. We recently demonstrated that cardiomyocyte (CM)-specific loss of the transcriptional orchestrator of oxidative metabolism PGC-1a leads to exercise-induced HF driven in part by maladaptive secreted proteins or myokines. These and other findings suggest that cardiomyocytes may activate a senescence-associated secretory phenotype (SASP), similarly to stress programs in other tissues, that mediate maladaptive remodeling. Yet the identity and function of SASP mediators in the heart remain unknown. Using transcriptomic analyses and heart extracellular fluid proteomics, we identified IGFBP5 as a PGC-1a–repressed SASP myokine whose expression increases under metabolic stress and correlates with atrophy, fibrosis, and senescence markers. CM IGFBP5 is increased in human HF but has never been examined in cardiomyocytes or in the context of exercise physiology. We hypothesize that IGFBP5 is a key cardiomyocyte SASP mediator that restricts physiologic cardiac growth during exercise and drives maladaptive remodeling when PGC-1a signaling is impaired. Aim 1 will test whether IGFBP5 gain-of-function is sufficient to impair physiologic hypertrophy, mitochondrial function, and exercise tolerance using AAV9-mediated overexpression in wild-type mice. Aim 2 will determine whether IGFBP5 loss-of-function rescues maladaptive remodeling and SASP activation in two murine models of HF. Aim 3 will define additional PGC-1a–suppressed SASP factors such as IGFBP5 through integrated secretomic and single-nucleus transcriptomic profiling of a metabolic model of HF characterized by elevated SASP. This work will provide a foundation for understanding how cardiomyocyte SASP programs govern adaptive versus maladaptive cardiac remodeling. It will also provide formative training in integrative cardiac myokine biology and HF physiology to support the candidate’s career development as an independent physician-scientist in cardiac physiology.
Amount: $231,000
Funding type: fellowship
Funder scheme: Career Development Award
Start date: 2026-04-01
End date: 2029-03-31
Subfield: Cell Biology
Funded outputs count: 0
Funder award ID: 26CDA1434802
OpenAlex ID: G8233457697